Fig. 3From: Experiences and consequences of phasing out substances of concern in a multinational healthcare companyOccurrence of the identified substances in the survey. NPE: nonylphenol ethoxylates; OPE: octylphenol ethoxylates; polar aprotic solvents: DMF: N,N-dimethylformamide; DMac: N,N-dimethylacetamide; NMP: N-methyl-2-pyrrolidoneBack to article page